OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of the European Academy of Dermatology and Venereology is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editor's Picks	234
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser	158
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	156
Two cases of anti‐TIF1‐γ antibody positive dermatomyositis with manifested symptoms after SARS‐CoV‐19 vaccination	144
The significance of exanthems in COVID‐19 patients hospitalized at a tertiary care centre	130
The role of genetic factors and peripheral immune cells in SAPHO syndrome	129
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin	126
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic	112
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	102
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	92
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	91
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	79
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry	72
Are non‐fungible tokens the barrier to realizing the Dermoverse?	71
Pharmacovigilance: The responsibility of all	63
Announcement	63
Chat GPT in dermatology: Progressive or problematic?	62
Announcement	62
	61
Assessing the efficacy of selective JAK inhibitors for alopecia areata with a patient‐centered approach	60
Dalbavancin for the treatment of severe hidradenitis suppurativa	59
Rosacea and upper gastrointestinal disorders: a case‐control study from a large, urban academic centre	59
Impact of menopause on the skin…information still insufficient	55
Announcement	53
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	52

Editor's Picks January 2024	52
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	52
Announcement	51
Issue Information	49
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	48
A case of eruptive halo nevi following COVID‐19	46
The chicken or the egg of lymphopenia in atopic eczema	45
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	45
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	45
Peer review, scientific publishing and the law of reciprocity	45
New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination	42
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti	42
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	42
Louis Adolphus Duhring: An enduring legacy	42
	42
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study	41
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	41
Educational, labour market and relationship outcomes in people with acne	41